Heart failure: systolic dysfunction and diastolic dysfunc-tion. The most common causes of systolic dysfunction (defined by a left-ventricular ejection fraction of 50%) are ischemic heart disease, idiopathic dilated cardiomyop-athy, hypertension, and valvular heart disease. Diastolic dysfunction (defined as dysfunction of left-ventricular fill. Lilly's Pathophysiology of Heart Disease.pdf - Google Drive.

1. Pathophysiology Of Disease Book
2. Pathophysiology Of Heart Disease Leonard Lilly Pdf Files In Word

Pathophysiology of Heart Disease A Collaborative Project of Medical Students and Faculty (Leonard S Lilly ) pdf torrent download, InfoHash.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (945K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

These references are in PubMed. This may not be the complete list of references from this article.

• Gheorghiade M, Bonow RO. Chronic heart failure in the United States: a manifestation of coronary artery disease. Circulation. 1998 Jan 27;97(3):282–289. [PubMed] [Google Scholar]
• Luppi P, Rudert WA, Zanone MM, Stassi G, Trucco G, Finegold D, Boyle GJ, Del Nido P, McGowan FX, Jr, Trucco M. Idiopathic dilated cardiomyopathy: a superantigen-driven autoimmune disease. Circulation. 1998 Aug 25;98(8):777–785. [PubMed] [Google Scholar]
• Katz AM. The cardiomyopathy of overload: an unnatural growth response in the hypertrophied heart. Ann Intern Med. 1994 Sep 1;121(5):363–371. [PubMed] [Google Scholar]
• McKay RG, Pfeffer MA, Pasternak RC, Markis JE, Come PC, Nakao S, Alderman JD, Ferguson JJ, Safian RD, Grossman W. Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. Circulation. 1986 Oct;74(4):693–702. [PubMed] [Google Scholar]
• Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol. 1996 Apr;27(5):1201–1206. [PubMed] [Google Scholar]
• Haywood GA, Tsao PS, von der Leyen HE, Mann MJ, Keeling PJ, Trindade PT, Lewis NP, Byrne CD, Rickenbacher PR, Bishopric NH, et al. Expression of inducible nitric oxide synthase in human heart failure. Circulation. 1996 Mar 15;93(6):1087–1094. [PubMed] [Google Scholar]
• Habib FM, Springall DR, Davies GJ, Oakley CM, Yacoub MH, Polak JM. Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet. 1996 Apr 27;347(9009):1151–1155. [PubMed] [Google Scholar]
• Anversa P, Kajstura J, Olivetti G. Myocyte death in heart failure. Curr Opin Cardiol. 1996 May;11(3):245–251. [PubMed] [Google Scholar]
• Bonow RO, Udelson JE. Left ventricular diastolic dysfunction as a cause of congestive heart failure. Mechanisms and management. Ann Intern Med. 1992 Sep 15;117(6):502–510. [PubMed] [Google Scholar]
• Bonow RO, Vitale DF, Bacharach SL, Frederick TM, Kent KM, Green MV. Asynchronous left ventricular regional function and impaired global diastolic filling in patients with coronary artery disease: reversal after coronary angioplasty. Circulation. 1985 Feb;71(2):297–307. [PubMed] [Google Scholar]
• Ferguson DW, Berg WJ, Sanders JS, Roach PJ, Kempf JS, Kienzle MG. Sympathoinhibitory responses to digitalis glycosides in heart failure patients. Direct evidence from sympathetic neural recordings. Circulation. 1989 Jul;80(1):65–77. [PubMed] [Google Scholar]
• Benedict CR. Neurohumoral aspects of heart failure. Cardiol Clin. 1994 Feb;12(1):9–23. [PubMed] [Google Scholar]
• Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984 Sep 27;311(13):819–823. [PubMed] [Google Scholar]
• Wei CM, Lerman A, Rodeheffer RJ, McGregor CG, Brandt RR, Wright S, Heublein DM, Kao PC, Edwards WD, Burnett JC., Jr Endothelin in human congestive heart failure. Circulation. 1994 Apr;89(4):1580–1586. [PubMed] [Google Scholar]
• Gottlieb SS, Kukin ML, Ahern D, Packer M. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. J Am Coll Cardiol. 1989 Jun;13(7):1534–1539. [PubMed] [Google Scholar]
• Pitt B, Segal R, Martinez FA, Meurers G, Cowley AJ, Thomas I, Deedwania PC, Ney DE, Snavely DB, Chang PI. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE) Lancet. 1997 Mar 15;349(9054):747–752. [PubMed] [Google Scholar]
• Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med. 1996 May 23;334(21):1349–1355. [PubMed] [Google Scholar]
• Heidenreich PA, Lee TT, Massie BM. Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials. J Am Coll Cardiol. 1997 Jul;30(1):27–34. [PubMed] [Google Scholar]
• Massin EK. Outpatient management of congestive heart failure. Tex Heart Inst J. 1998;25(4):238–250.[PMC free article] [PubMed] [Google Scholar]
• Frazier OH, Macris MP, Myers TJ, Duncan JM, Radovancević B, Parnis SM, Cooley DA. Improved survival after extended bridge to cardiac transplantation. Ann Thorac Surg. 1994 Jun;57(6):1416–1422. [PubMed] [Google Scholar]
• Pennington DG, McBride LR, Peigh PS, Miller LW, Swartz MT. Eight years' experience with bridging to cardiac transplantation. J Thorac Cardiovasc Surg. 1994 Feb;107(2):472–481. [PubMed] [Google Scholar]
• DeRose JJ, Jr, Umana JP, Argenziano M, Catanese KA, Gardocki MT, Flannery M, Levin HR, Sun BC, Rose EA, Oz MC. Implantable left ventricular assist devices provide an excellent outpatient bridge to transplantation and recovery. J Am Coll Cardiol. 1997 Dec;30(7):1773–1777. [PubMed] [Google Scholar]
• Frazier OH, Benedict CR, Radovancevic B, Bick RJ, Capek P, Springer WE, Macris MP, Delgado R, Buja LM. Improved left ventricular function after chronic left ventricular unloading. Ann Thorac Surg. 1996 Sep;62(3):675–682. [PubMed] [Google Scholar]
• Altemose GT, Gritsus V, Jeevanandam V, Goldman B, Margulies KB. Altered myocardial phenotype after mechanical support in human beings with advanced cardiomyopathy. J Heart Lung Transplant. 1997 Jul;16(7):765–773. [PubMed] [Google Scholar]
• Müller J, Wallukat G, Weng YG, Dandel M, Spiegelsberger S, Semrau S, Brandes K, Theodoridis V, Loebe M, Meyer R, et al. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation. 1997 Jul 15;96(2):542–549. [PubMed] [Google Scholar]
• Mestroni L, Giacca M. Molecular genetics of dilated cardiomyopathy. Curr Opin Cardiol. 1997 May;12(3):303–309. [PubMed] [Google Scholar]
• Roberts R, Marian AJ, Bachinski L. Molecular genetics of hypertrophic cardiomyopathy. J Card Fail. 1996 Dec;2(4 Suppl):S87–S95. [PubMed] [Google Scholar]
• Marian AJ, Roberts R. Molecular genetic basis of hypertrophic cardiomyopathy: genetic markers for sudden cardiac death. J Cardiovasc Electrophysiol. 1998 Jan;9(1):88–99. [PubMed] [Google Scholar]

Associated Data

Supplementary Materials

See a Problem?

Preview — Pathophysiology of Heart Disease by Leonard S. Lilly

Pathophysiology Of Disease Book

Be the first to ask a question about Pathophysiology of Heart Disease

Pathophysiology Of Heart Disease Leonard Lilly Pdf Files In Word